Persistent SARS-CoV-2 infection: significance and implications.

SARS-CoV-2 causes persistent infections in a subset of individuals, which is a major clinical and public health problem that should be prioritised for further investigation for several reasons. First, persistent SARS-CoV-2 infection often goes unrecognised, and therefore might affect a substantial number of people, particularly immunocompromised individuals. Second, the formation of tissue reservoirs (including in non-respiratory tissues) might underlie the pathophysiology of the persistent SARS-CoV-2 infection and require new strategies for diagnosis and treatment. Finally, persistent SARS-CoV-2 replication, particularly in the setting of suboptimal immune responses, is a possible source of new, divergent virus variants that escape pre-existing immunity on the individual and population levels. Defining optimal diagnostic and treatment strategies for patients with persistent virus replication and monitoring viral evolution are therefore urgent medical and public health priorities.
Competing Interests: Declaration of interests HMM was awarded funding for this work by the US National Institutes of Health (grant number T32AI055397). HMM, DHO'C, and TCF are funded by Centers for Disease Control and Prevention (CDC) contract 75D30121C11060. AMH and NDG are supported by CDC contract 75D30122C14697. DHO, TCF, and MCJ have a provisional patent on cryptic lineages covering methods for using viral sequences detected in wastewater to forecast and evaluate viral variants that might become dominant in the general population in the future. DHO has a pending patent on membrane-specific antibody responses that describes that the membrane ectodomain is a frequent target of SARS-CoV-2-specific antibodies and that this region could be used instead of or in addition to other serological diagnostics. JGW, PJH, JEL, AP, and WW declare no competing interests.
(Copyright © 2024 Elsevier Ltd. All rights reserved.)